TG-Gln, a substrate-type crosslinking agent with the sequence H-NQEQVSPLERCG-NH2 serving as a glutamine donor peptide, is designed to target activated coagulation factor XIII transglutaminase (FXIIIa). This compound shows promise for regenerative medicine applications, such as inducing angiogenesis, cartilage repair, and wound healing.
Molekulargewicht:
1358.5
CAS Nummer:
[948889-16-5]
Formel:
C54H91N19O20S
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
